Abstract 4256: YH012, a novel bispecific anti-HER2 and TROP2 antibody-drug conjugate, exhibits potent antitumor efficacy

已取消 20 由 karry 发布于 2026/7/15 15:57:48

DOI:10.1158/1538-7445.am2022-4256
作者：Chengzhang Shang,?Liu Yang,?Jiyong Zhang,?Yanfei Han,?Zhuolin Li,?Z. Han,?Jun Li,?Ying Meng,?G. An,?Hao Yang,?W. An,?Lei Chen,?John C. Charpentier
文献类型：期刊论文
补充材料：只需要正文

American Association for Cancer Research (AACR)

Abstract： Bispecific antibodies (BsAbs) and antibody-drug conjugates (ADCs) are among the most promising and fastest growing classes of next-generation antibody therapeutics for cancer therapy. The

应助信息

7小时前

Book学术机器人

2026/7/15 15:57:48 未找到该文献，机器人已退出，请等待人工下载

2026/7/15 15:57:48 Book学术AI机器人收到请求，开始寻找文献

2026/7/15 15:57:48 已向机器人发送请求

7小时前

karry 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierHigh efficiency biosynthesis of 1α,25-Dihydroxyvitamin D3 via engineered dihydroxylase and deep eutectic solvent based resting cell bioprocess